MetaADEDB 2.0 @ LMMD
Liraglutide
(YSDQQAXHVYUZIW-QCIJIYAXSA-N)
Structure
SMILES
CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)O)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CCCNC(=N)N)CCCNC(=N)N)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C
Molecular Formula:
C172H265N43O51
Molecular Weight:
3751.200
Log P:
6.1296
Hydrogen Bond Acceptor:
92
Hydrogen Bond Donor:
54
TPSA:
1513.76
CAS Number(s):
204656-20-2
Synonym(s)
1.
Liraglutide
2.
NN 2211
3.
NN-2211
4.
NN2211
5.
Saxenda
6.
Victoza
7.
2211, NN
External Link(s)
MeSHD000069450
PubChem Compound16153050
16134956
BindingDB50240819
ChEBI71193
CHEMBLCHEMBL4084119
DrugCentral4164
IUPHAR/BPS Guide to PHARMACOLOGY1133
Therapeutic Target DatabaseD03GOI
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 4280
Canada Vigilance: 81
Canada Vigilance
SIDER
US FAERS
2VomitingFAERS: 1573
Canada Vigilance: 34
Canada Vigilance
SIDER
US FAERS
3Blood glucose increasedFAERS: 1536US FAERS
4PancreatitisFAERS: 1396
Canada Vigilance: 17
Canada Vigilance
SIDER
US FAERS
5HeadacheFAERS: 1012
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
6Weight decreasedFAERS: 916US FAERS
7ConstipationFAERS: 715
Canada Vigilance: 38
Canada Vigilance
SIDER
US FAERS
8MalaiseFAERS: 581
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
9DizzinessFAERS: 577
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
10Abdominal discomfortFAERS: 558
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
11FatigueFAERS: 536
Canada Vigilance: 24
Canada Vigilance
SIDER
US FAERS
12EructationFAERS: 514
Canada Vigilance: 15
Canada Vigilance
US FAERS
13Drug ineffectiveFAERS: 487
Canada Vigilance: 23
Canada Vigilance
US FAERS
14Injection site erythemaFAERS: 467
Canada Vigilance: 7
Canada Vigilance
US FAERS
15Injection site painFAERS: 464
Canada Vigilance: 5
Canada Vigilance
US FAERS
16Abdominal PainFAERS: 435
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
17Blood glucose decreasedFAERS: 425
Canada Vigilance: 6
Canada Vigilance
US FAERS
18DyspepsiaFAERS: 408
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
19FlatulenceFAERS: 340
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
20Injection site pruritusFAERS: 339
Canada Vigilance: 8
Canada Vigilance
US FAERS
21Injection Site ReactionFAERS: 311
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
22AstheniaFAERS: 298
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
23Pancreatic carcinomaFAERS: 276US FAERS
24Device malfunctionFAERS: 249US FAERS
25Back PainFAERS: 231
Canada Vigilance: 3
Canada Vigilance
US FAERS
26Injection site urticariaFAERS: 219US FAERS
27DysgeusiaFAERS: 203
Canada Vigilance: 6
Canada Vigilance
US FAERS
28Injection site bruisingFAERS: 184
Canada Vigilance: 10
Canada Vigilance
US FAERS
29PruritusFAERS: 182
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
30UrticariaFAERS: 174
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
31AlopeciaFAERS: 166
Canada Vigilance: 2
Canada Vigilance
US FAERS
32Lipase increasedFAERS: 165
Canada Vigilance: 2
Canada Vigilance
US FAERS
33DehydrationFAERS: 162
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
34Product quality issueFAERS: 162
Canada Vigilance: 2
Canada Vigilance
US FAERS
35PainFAERS: 156
Canada Vigilance: 3
Canada Vigilance
US FAERS
36Drug dose omissionFAERS: 150US FAERS
37Feeling abnormalFAERS: 135
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
38HungerFAERS: 122
Canada Vigilance: 7
Canada Vigilance
US FAERS
39CholelithiasisFAERS: 117
Canada Vigilance: 12
Canada Vigilance
US FAERS
40HypersensitivityFAERS: 108
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
41Incorrect dose administeredFAERS: 108
Canada Vigilance: 1
Canada Vigilance
US FAERS
42PalpitationsFAERS: 107
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
43Injection site massFAERS: 105US FAERS
44TremorFAERS: 104
Canada Vigilance: 1
Canada Vigilance
US FAERS
45SomnolenceFAERS: 98
Canada Vigilance: 3
Canada Vigilance
US FAERS
46Chest PainFAERS: 97
Canada Vigilance: 1
Canada Vigilance
US FAERS
47Product use issueFAERS: 96
Canada Vigilance: 8
Canada Vigilance
US FAERS
48DysphoniaFAERS: 93US FAERS
49ArthralgiaFAERS: 92
Canada Vigilance: 3
Canada Vigilance
US FAERS
50Diabetes mellitus inadequate controlFAERS: 85US FAERS
51Urinary tract infectionFAERS: 79
Canada Vigilance: 2
Canada Vigilance
US FAERS
52MyalgiaFAERS: 76US FAERS
53Incorrect product storageFAERS: 73US FAERS
54Product use in unapproved indicationFAERS: 73US FAERS
55Blood glucose fluctuationFAERS: 72US FAERS
56ChillsFAERS: 66US FAERS
57Oropharyngeal painFAERS: 65
Canada Vigilance: 3
Canada Vigilance
US FAERS
58AnxietyFAERS: 62US FAERS
59Impaired gastric emptyingFAERS: 62US FAERS
60LethargyFAERS: 59US FAERS
61InfluenzaFAERS: 53
Canada Vigilance: 6
Canada Vigilance
US FAERS
62Drug dose titration not performedFAERS: 52
Canada Vigilance: 3
Canada Vigilance
US FAERS
63Visual ImpairmentFAERS: 51US FAERS
64Thyroid NeoplasmFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
65NasopharyngitisFAERS: 47
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
66Chest discomfortFAERS: 46US FAERS
67RetchingFAERS: 46
Canada Vigilance: 2
Canada Vigilance
US FAERS
68Device FailureFAERS: 45US FAERS
69Blood glucose abnormalFAERS: 44US FAERS
70Amylase increasedFAERS: 43US FAERS
71Cerebrovascular accidentFAERS: 43
Canada Vigilance: 1
Canada Vigilance
US FAERS
72ErythemaFAERS: 43SIDER
US FAERS
73Diabetic KetoacidosisFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
74Extra dose administeredFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
75HyperchlorhydriaFAERS: 40US FAERS
76HypotensionFAERS: 39
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
77SwellingFAERS: 39US FAERS
78NervousnessFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
79Wrong technique in product usage processFAERS: 38
Canada Vigilance: 8
Canada Vigilance
US FAERS
80Feeling jitteryFAERS: 37US FAERS
81Injection site extravasationFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
82Lip swellingFAERS: 35
Canada Vigilance: 4
Canada Vigilance
US FAERS
83Unevaluable eventFAERS: 35US FAERS
84Injury associated with deviceFAERS: 34US FAERS
85Neck PainFAERS: 34US FAERS
86Injection site irritationFAERS: 33US FAERS
87TachycardiaFAERS: 33SIDER
US FAERS
88Atrial FibrillationFAERS: 32US FAERS
89Blood creatinine increasedFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
90Drug titration errorFAERS: 32
Canada Vigilance: 7
Canada Vigilance
US FAERS
91Needle issueFAERS: 32US FAERS
92Food cravingFAERS: 31
Canada Vigilance: 7
Canada Vigilance
US FAERS
93NephrolithiasisFAERS: 31
Canada Vigilance: 5
Canada Vigilance
US FAERS
94Accidental overdoseFAERS: 30US FAERS
95Incorrect storage of drugFAERS: 30US FAERS
96Injection site noduleFAERS: 30US FAERS
97Blood amylase increasedFAERS: 29US FAERS
98Bowel movement irregularityFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
99Myocardial InfarctionFAERS: 29
Canada Vigilance: 3
Canada Vigilance
US FAERS
100PregnancyFAERS: 29US FAERS
101SyncopeFAERS: 29
Canada Vigilance: 4
Canada Vigilance
US FAERS
102Throat irritationFAERS: 29US FAERS
103ArthritisFAERS: 28
Canada Vigilance: 2
Canada Vigilance
US FAERS
104CholecystitisFAERS: 28
Canada Vigilance: 4
Canada Vigilance
US FAERS
105Cold sweatFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
106PneumoniaFAERS: 28
Canada Vigilance: 5
Canada Vigilance
US FAERS
107Burning sensationFAERS: 27US FAERS
108Pancreatic enzymes increasedFAERS: 27US FAERS
109SinusitisFAERS: 27US FAERS
110NoduleFAERS: 26US FAERS
111Adverse eventFAERS: 25US FAERS
112DysuriaFAERS: 25US FAERS
113GastritisFAERS: 25SIDER
US FAERS
114No adverse eventFAERS: 25US FAERS
115Peripheral swellingFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
116BronchitisFAERS: 24
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
117Wrong technique in drug usage processFAERS: 24US FAERS
118Acute kidney injuryFAERS: 23US FAERS
119Feeling ColdFAERS: 23US FAERS
120Memory impairmentFAERS: 23US FAERS
121Musculoskeletal PainFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Product storage errorFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
123Therapeutic response unexpectedFAERS: 23US FAERS
124ThirstFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
125BlindnessFAERS: 22US FAERS
126CataractFAERS: 22US FAERS
127FlushingFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
128DiscomfortFAERS: 21
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
129DiverticulitisFAERS: 21
Canada Vigilance: 4
Canada Vigilance
US FAERS
130Dry skinFAERS: 21US FAERS
131Incorrect route of drug administrationFAERS: 21US FAERS
132Injection site warmthFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
133Pancreatic NeoplasmFAERS: 21US FAERS
134Skin reactionFAERS: 21US FAERS
135AngioedemaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
136HepatitisFAERS: 20US FAERS
137Incorrect dose administered by deviceFAERS: 20US FAERS
138Musculoskeletal stiffnessFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
139AphagiaFAERS: 19US FAERS
140CystitisFAERS: 19US FAERS
141Depressed moodFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
142Device leakageFAERS: 19US FAERS
143DisabilityFAERS: 19US FAERS
144GoutFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
145Blood triglycerides increasedFAERS: 18US FAERS
146ColitisFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
147Injection site vesiclesFAERS: 18US FAERS
148Intestinal ObstructionFAERS: 18SIDER
US FAERS
149StressFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
150VertigoFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Alanine Aminotransferase IncreasedFAERS: 17US FAERS
152HypersomniaFAERS: 17US FAERS
153Mood swingsFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
154OverdoseFAERS: 17US FAERS
155TinnitusFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
156AgeusiaFAERS: 16US FAERS
157ChromaturiaFAERS: 16US FAERS
158Joint swellingFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
159LymphadenopathyFAERS: 16US FAERS
160ArthropathyFAERS: 15US FAERS
161Aspartate Aminotransferase IncreasedFAERS: 15US FAERS
162Erectile dysfunctionFAERS: 15US FAERS
163Injection site discomfortFAERS: 15US FAERS
164Injection site hypersensitivityFAERS: 15US FAERS
165Injection site inflammationFAERS: 15US FAERS
166Intentional product misuseFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
167AphoniaFAERS: 14US FAERS
168Blood urine presentFAERS: 14
Canada Vigilance: 3
Canada Vigilance
US FAERS
169Deep Vein ThrombosisFAERS: 14US FAERS
170Drug prescribing errorFAERS: 14US FAERS
171GastroenteritisFAERS: 14US FAERS
172Inappropriate schedule of drug administrationFAERS: 14US FAERS
173Pancreatic CystFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
174AgitationFAERS: 13US FAERS
175Blood calcitonin increasedFAERS: 13US FAERS
176HypothyroidismFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
177Limb discomfortFAERS: 13US FAERS
178Medication ErrorFAERS: 13US FAERS
179Product contamination with body fluidFAERS: 13US FAERS
180RegurgitationFAERS: 13US FAERS
181SluggishnessFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
182Blood thyroid stimulating hormone increasedFAERS: 12US FAERS
183CellulitisFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
184Gastrointestinal PainFAERS: 12SIDER
US FAERS
185PresyncopeFAERS: 12US FAERS
186Renal painFAERS: 12US FAERS
187AmnesiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
188AppendicitisFAERS: 11US FAERS
189Blood potassium decreasedFAERS: 11US FAERS
190Diabetic RetinopathyFAERS: 11US FAERS
191Gastric ulcerFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
192Liquid product physical issueFAERS: 11US FAERS
193Oral painFAERS: 11US FAERS
194SepsisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
195Blood cholesterol increasedFAERS: 10US FAERS
196Cardiac ArrestFAERS: 10US FAERS
197Drug administration errorFAERS: 10US FAERS
198EpistaxisFAERS: 10US FAERS
199Gastrointestinal sounds abnormalFAERS: 10US FAERS
200General physical health deteriorationFAERS: 10US FAERS
201HyperthyroidismFAERS: 10US FAERS
202Injection site lacerationFAERS: 10US FAERS
203Poor quality sleepFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
204Device breakageFAERS: 9US FAERS
205Drug ineffective for unapproved indicationFAERS: 9US FAERS
206Expired product administeredFAERS: 9US FAERS
207Food PoisoningFAERS: 9US FAERS
208GlaucomaFAERS: 9US FAERS
209Head discomfortFAERS: 9US FAERS
210IleusFAERS: 9US FAERS
211Intentional product use issueFAERS: 9
Canada Vigilance: 5
Canada Vigilance
US FAERS
212Musculoskeletal discomfortFAERS: 9US FAERS
213PsoriasisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
214SneezingFAERS: 9US FAERS
215Urinary RetentionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
216Abdominal tendernessFAERS: 8US FAERS
217AngerFAERS: 8US FAERS
218Benign neoplasm of thyroid glandFAERS: 8US FAERS
219Cholecystitis infectiveFAERS: 8US FAERS
220Diabetes MellitusFAERS: 8US FAERS
221Eye painFAERS: 8US FAERS
222Gastric DilatationFAERS: 8US FAERS
223HypophagiaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
224Intentional dose omissionFAERS: 8
Canada Vigilance: 3
Canada Vigilance
US FAERS
225Irritable Bowel SyndromeFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
226LaryngitisFAERS: 8US FAERS
227Lower respiratory tract infectionFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
228LymphomaFAERS: 8US FAERS
229RestlessnessFAERS: 8US FAERS
230Therapy cessationFAERS: 8US FAERS
231ThrombocytopeniaFAERS: 8US FAERS
232Urinary IncontinenceFAERS: 8US FAERS
233jaundiceFAERS: 8US FAERS
234AcneFAERS: 7US FAERS
235Anaphylactic shockFAERS: 7SIDER
US FAERS
236Bladder painFAERS: 7US FAERS
237CholestasisFAERS: 7US FAERS
238Device difficult to useFAERS: 7US FAERS
239DiplopiaFAERS: 7US FAERS
240DisorientationFAERS: 7US FAERS
241EpilepsyFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
242Gallbladder painFAERS: 7US FAERS
243HepatomegalyFAERS: 7US FAERS
244Infrequent bowel movementsFAERS: 7US FAERS
245Injection site injuryFAERS: 7US FAERS
246Joint injuryFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
247Lack of satietyFAERS: 7US FAERS
248Muscle tightnessFAERS: 7US FAERS
249Night sweatsFAERS: 7US FAERS
250Pancreatic PseudocystFAERS: 7US FAERS
251Product physical issueFAERS: 7US FAERS
252Pulmonary EmbolismFAERS: 7US FAERS
253Renal Cell CarcinomaFAERS: 7US FAERS
254WheezingFAERS: 7US FAERS
255Angina PectorisFAERS: 6US FAERS
256AsthmaFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
257ChokingFAERS: 6US FAERS
258CholangitisFAERS: 6US FAERS
259DermatomyositisFAERS: 6US FAERS
260DysarthriaFAERS: 6US FAERS
261Ear discomfortFAERS: 6US FAERS
262EczemaFAERS: 6US FAERS
263Expired drug administeredFAERS: 6US FAERS
264Gastric pH decreasedFAERS: 6US FAERS
265Limb injuryFAERS: 6
Canada Vigilance: 4
Canada Vigilance
US FAERS
266Musculoskeletal chest painFAERS: 6US FAERS
267Product dose omissionFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
268Sinus headacheFAERS: 6US FAERS
269Skin UlcerFAERS: 6US FAERS
270Skin irritationFAERS: 6US FAERS
271StomatitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
272Supraventricular tachycardiaFAERS: 6US FAERS
273ThrombosisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
274Vulvovaginal pruritusFAERS: 6US FAERS
275prostatitisFAERS: 6US FAERS
276AbasiaFAERS: 5US FAERS
277Acute myocardial infarctionFAERS: 5US FAERS
278ApathyFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
279Autoimmune hepatitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
280Back disorderFAERS: 5US FAERS
281BedriddenFAERS: 5US FAERS
282Biliary ColicFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
283Blood alkaline phosphatase increasedFAERS: 5US FAERS
284Blood magnesium decreasedFAERS: 5US FAERS
285Blood thyroid stimulating hormone decreasedFAERS: 5US FAERS
286Blood urea increasedFAERS: 5US FAERS
287EnteritisFAERS: 5US FAERS
288Food aversionFAERS: 5US FAERS
289Gamma-Glutamyltransferase IncreasedFAERS: 5US FAERS
290HyperphagiaFAERS: 5US FAERS
291InfectionFAERS: 5SIDER
US FAERS
292Injection site infectionFAERS: 5US FAERS
293Metabolic acidosisFAERS: 5US FAERS
294NephritisFAERS: 5US FAERS
295PolyuriaFAERS: 5US FAERS
296Rash erythematousFAERS: 5US FAERS
297Sudden deathFAERS: 5US FAERS
298Thirst decreasedFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
299Vulvovaginal mycotic infectionFAERS: 5US FAERS
300furuncleFAERS: 5US FAERS
301Accidental exposureFAERS: 4US FAERS
302Altered state of consciousnessFAERS: 4US FAERS
303AnosmiaFAERS: 4US FAERS
304AphasiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
305Blood creatine increasedFAERS: 4US FAERS
306Blood parathyroid hormone decreasedFAERS: 4US FAERS
307Blood potassium increasedFAERS: 4US FAERS
308Blood testosterone decreasedFAERS: 4US FAERS
309Breast cancer recurrentFAERS: 4US FAERS
310Cardiac FlutterFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
311Colon adenomaFAERS: 4US FAERS
312CryingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
313CystFAERS: 4US FAERS
314DeafnessFAERS: 4US FAERS
315DuodenitisFAERS: 4US FAERS
316EosinophiliaFAERS: 4US FAERS
317Eye irritationFAERS: 4US FAERS
318FibromyalgiaFAERS: 4US FAERS
319Flank PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
320Gastrointestinal inflammationFAERS: 4US FAERS
321Injection site abscessFAERS: 4US FAERS
322Injection site scarFAERS: 4US FAERS
323Intraductal papillary mucinous neoplasmFAERS: 4US FAERS
324LacerationFAERS: 4US FAERS
325Local reactionFAERS: 4US FAERS
326Malabsorption from injection siteFAERS: 4US FAERS
327MenorrhagiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
328Myasthenia GravisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
329PallorFAERS: 4US FAERS
330PancytopeniaFAERS: 4US FAERS
331ParanoiaFAERS: 4US FAERS
332Pelvic PainFAERS: 4US FAERS
333Product complaintFAERS: 4US FAERS
334Product taste abnormalFAERS: 4US FAERS
335Respiratory FailureFAERS: 4US FAERS
336Respiratory arrestFAERS: 4US FAERS
337RhabdomyolysisFAERS: 4US FAERS
338RhinitisFAERS: 4US FAERS
339Skin lesionFAERS: 4US FAERS
340SplenomegalyFAERS: 4US FAERS
341Suicide attemptFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
342Transaminases increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
343VIIth nerve paralysisFAERS: 4US FAERS
344Vulvovaginal discomfortFAERS: 4US FAERS
345White blood cell count decreasedFAERS: 4US FAERS
346nervous system disorderFAERS: 4SIDER
US FAERS
347Abdominal massFAERS: 3US FAERS
348Ankle FractureFAERS: 3US FAERS
349Autoimmune thyroiditisFAERS: 3US FAERS
350Blood creatine phosphokinase increasedFAERS: 3US FAERS
351Blood creatinine abnormalFAERS: 3US FAERS
352Blood pressure fluctuationFAERS: 3US FAERS
353CardiomegalyFAERS: 3US FAERS
354Cerebral InfarctionFAERS: 3US FAERS
355Choking sensationFAERS: 3US FAERS
356Completed SuicideFAERS: 3US FAERS
357Depressed Level of ConsciousnessFAERS: 3US FAERS
358DermatitisFAERS: 3SIDER
US FAERS
359DiverticulumFAERS: 3US FAERS
360Duodenal ulcer perforationFAERS: 3US FAERS
361Euphoric moodFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
362Facial paralysisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
363Feeling of body temperature changeFAERS: 3US FAERS
364FormicationFAERS: 3US FAERS
365Gastrointestinal carcinomaFAERS: 3US FAERS
366Gastrointestinal infectionFAERS: 3US FAERS
367GranulomaFAERS: 3US FAERS
368HemiplegiaFAERS: 3US FAERS
369HordeolumFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
370HyperlipasaemiaFAERS: 3US FAERS
371HypogeusiaFAERS: 3US FAERS
372HysterectomyFAERS: 3
Canada Vigilance: 4
Canada Vigilance
US FAERS
373Inappropriate schedule of product administrationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
374IncontinenceFAERS: 3US FAERS
375Intentional drug misuseFAERS: 3US FAERS
376Invasive Ductal Breast CarcinomaFAERS: 3US FAERS
377Joint stiffnessFAERS: 3US FAERS
378KetoacidosisFAERS: 3US FAERS
379Lactose IntoleranceFAERS: 3US FAERS
380Lichen PlanusFAERS: 3US FAERS
381Lipodystrophy acquiredFAERS: 3US FAERS
382MalnutritionFAERS: 3SIDER
US FAERS
383MastitisFAERS: 3US FAERS
384Mesenteric PanniculitisFAERS: 3US FAERS
385Migraine with AuraFAERS: 3US FAERS
386Mouth swellingFAERS: 3US FAERS
387Multiple MyelomaFAERS: 3US FAERS
388NocturiaFAERS: 3US FAERS
389Nonspecific reactionFAERS: 3US FAERS
390ObesityFAERS: 3US FAERS
391Ocular icterusFAERS: 3US FAERS
392OnychoclasisFAERS: 3US FAERS
393Oropharyngeal blisteringFAERS: 3US FAERS
394Pain of skinFAERS: 3US FAERS
395Pancreatic enlargementFAERS: 3US FAERS
396Post-Traumatic Stress DisorderFAERS: 3US FAERS
397Prescription drug used without a prescriptionFAERS: 3US FAERS
398Protein total abnormalFAERS: 3US FAERS
399ProteinuriaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
400Restless Legs SyndromeFAERS: 3US FAERS
401Retinal Vein OcclusionFAERS: 3US FAERS
402Rheumatoid ArthritisFAERS: 3US FAERS
403RosaceaFAERS: 3US FAERS
404ScabFAERS: 3US FAERS
405SciaticaFAERS: 3US FAERS
406Septic ShockFAERS: 3US FAERS
407Sexual DysfunctionFAERS: 3US FAERS
408Tension HeadacheFAERS: 3US FAERS
409Therapy changeFAERS: 3US FAERS
410Thyroid cancer metastaticFAERS: 3US FAERS
411ThyroidectomyFAERS: 3US FAERS
412ToothacheFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
413UlcerFAERS: 3US FAERS
414Upper-airway cough syndromeFAERS: 3US FAERS
415VasculitisFAERS: 3US FAERS
416Venous thrombosis limbFAERS: 3US FAERS
417Vulvovaginal burning sensationFAERS: 3US FAERS
418Wrong technique in device usage processFAERS: 3US FAERS
419Abdominal rigidityFAERS: 2US FAERS
420Accidental exposure to productFAERS: 2US FAERS
421Accidental underdoseFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
422Acute respiratory failureFAERS: 2US FAERS
423AdenocarcinomaFAERS: 2US FAERS
424AmyloidosisFAERS: 2US FAERS
425Anorectal discomfortFAERS: 2US FAERS
426Antibody test positiveFAERS: 2US FAERS
427AnuriaFAERS: 2US FAERS
428Aphthous StomatitisFAERS: 2US FAERS
429AscitesFAERS: 2US FAERS
430AsphyxiaFAERS: 2US FAERS
431AsthenopiaFAERS: 2US FAERS
432Benign NeoplasmFAERS: 2US FAERS
433Biliary DyskinesiaFAERS: 2US FAERS
434Blood creatinine decreasedFAERS: 2US FAERS
435Blood iron decreasedFAERS: 2US FAERS
436Blood parathyroid hormone increasedFAERS: 2US FAERS
437Blood triglycerides decreasedFAERS: 2US FAERS
438BradycardiaFAERS: 2US FAERS
439Breast CystFAERS: 2US FAERS
440Breast tendernessFAERS: 2US FAERS
441CandidiasisFAERS: 2US FAERS
442Carbohydrate antigen 19-9 increasedFAERS: 2US FAERS
443Cataract operationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
444CheilitisFAERS: 2US FAERS
445CholangiocarcinomaFAERS: 2US FAERS
446Clostridium difficile infectionFAERS: 2US FAERS
447Cluster HeadacheFAERS: 2US FAERS
448ConjunctivitisFAERS: 2US FAERS
449Corneal graft rejectionFAERS: 2US FAERS
450Coronary Artery DiseaseFAERS: 2US FAERS
451Device occlusionFAERS: 2US FAERS
452Disease recurrenceFAERS: 2US FAERS
453Drug administered to patient of inappropriate ageFAERS: 2US FAERS
454Drug exposure during pregnancyFAERS: 2US FAERS
455Drug resistanceFAERS: 2US FAERS
456Drug withdrawal headacheFAERS: 2US FAERS
457EcchymosisFAERS: 2US FAERS
458Ejection Fraction DecreasedFAERS: 2US FAERS
459Electrolyte imbalanceFAERS: 2US FAERS
460Emergency CareFAERS: 2US FAERS
461Emotional distressFAERS: 2US FAERS
462Enzyme level increasedFAERS: 2US FAERS
463Erection increasedFAERS: 2US FAERS
464Erythema NodosumFAERS: 2US FAERS
465Eye InfectionFAERS: 2US FAERS
466Facial PainFAERS: 2US FAERS
467Gait inabilityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
468GastrectomyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
469Gastric infectionFAERS: 2US FAERS
470Genital abscessFAERS: 2US FAERS
471GingivitisFAERS: 2US FAERS
472Hepatic cancer metastaticFAERS: 2US FAERS
473Hepatic enzyme decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
474Hepatobiliary scan abnormalFAERS: 2US FAERS
475HerniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
476HirsutismFAERS: 2US FAERS
477HyperparathyroidismFAERS: 2US FAERS
478HyperventilationFAERS: 2US FAERS
479Hypoaesthesia facialFAERS: 2US FAERS
480HypoxiaFAERS: 2US FAERS
481ImmobileFAERS: 2US FAERS
482Immune thrombocytopenic purpuraFAERS: 2US FAERS
483Incorrect drug administration rateFAERS: 2US FAERS
484Increased upper airway secretionFAERS: 2US FAERS
485InflammationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
486Initial insomniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
487Injection site atrophyFAERS: 2US FAERS
488Injection site cellulitisFAERS: 2US FAERS
489Injection site cystFAERS: 2US FAERS
490Injection site drynessFAERS: 2US FAERS
491Injection site thrombosisFAERS: 2US FAERS
492Intentional device misuseFAERS: 2US FAERS
493Intercepted product prescribing errorFAERS: 2US FAERS
494Intestinal PerforationFAERS: 2US FAERS
495Intracranial AneurysmFAERS: 2US FAERS
496LeukocytosisFAERS: 2US FAERS
497Limb operationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
498Lipase abnormalFAERS: 2US FAERS
499LipomaFAERS: 2US FAERS
500MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
501Meniscus injuryFAERS: 2US FAERS
502Metastatic NeoplasmFAERS: 2US FAERS
503MetrorrhagiaFAERS: 2US FAERS
504MonoplegiaFAERS: 2US FAERS
505Multiple SclerosisFAERS: 2US FAERS
506Muscle strainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
507MyelofibrosisFAERS: 2US FAERS
508MyopathyFAERS: 2US FAERS
509MyopiaFAERS: 2US FAERS
510Nasal pruritusFAERS: 2US FAERS
511Nephrotic SyndromeFAERS: 2US FAERS
512Nerve injuryFAERS: 2US FAERS
513NeuralgiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
514Non-cardiac chest painFAERS: 2US FAERS
515Optic NeuritisFAERS: 2US FAERS
516Oral fungal infectionFAERS: 2US FAERS
517Oral pruritusFAERS: 2US FAERS
518OsteomyelitisFAERS: 2US FAERS
519Pancreatic carcinoma stage IIIFAERS: 2US FAERS
520Panic DisorderFAERS: 2US FAERS
521PertussisFAERS: 2US FAERS
522PetechiaeFAERS: 2US FAERS
523PharyngitisFAERS: 2US FAERS
524PhotophobiaFAERS: 2US FAERS
525PoisoningFAERS: 2US FAERS
526Portal Vein ThrombosisFAERS: 2US FAERS
527Prescribed underdoseFAERS: 2US FAERS
528Product contaminationFAERS: 2US FAERS
529Product prescribing errorFAERS: 2US FAERS
530PseudocystFAERS: 2US FAERS
531Pulmonary FibrosisFAERS: 2US FAERS
532Quality of life decreasedFAERS: 2US FAERS
533Reflux gastritisFAERS: 2US FAERS
534Renal cystFAERS: 2US FAERS
535Renal tubular necrosisFAERS: 2US FAERS
536Respiratory distressFAERS: 2US FAERS
537SarcoidosisFAERS: 2US FAERS
538Secretion dischargeFAERS: 2US FAERS
539Sinus TachycardiaFAERS: 2US FAERS
540Skin lacerationFAERS: 2US FAERS
541Skin texture abnormalFAERS: 2US FAERS
542Skin tightnessFAERS: 2US FAERS
543SomnambulismFAERS: 2US FAERS
544Spinal column stenosisFAERS: 2US FAERS
545Squamous cell carcinomaFAERS: 2US FAERS
546Stress at workFAERS: 2US FAERS
547Subcutaneous AbscessFAERS: 2US FAERS
548SunburnFAERS: 2US FAERS
549Synovial CystFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
550Temperature intoleranceFAERS: 2US FAERS
551TensionFAERS: 2US FAERS
552Throat cancerFAERS: 2US FAERS
553Thyroid hormones increasedFAERS: 2US FAERS
554ThyroiditisFAERS: 2US FAERS
555Tooth LossFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
556Toxicity to various agentsFAERS: 2US FAERS
557TrichorrhexisFAERS: 2US FAERS
558Umbilical herniaFAERS: 2US FAERS
559Urinary hesitationFAERS: 2US FAERS
560Vaginal DischargeFAERS: 2US FAERS
561Vascular occlusionFAERS: 2US FAERS
562Ventricular FibrillationFAERS: 2US FAERS
563Vitreous floatersFAERS: 2US FAERS
564Vulvovaginal drynessFAERS: 2US FAERS
565Vulvovaginal painFAERS: 2US FAERS
566Wrong drug administeredFAERS: 2US FAERS
567treatment failureFAERS: 2US FAERS
568Abdominal InfectionFAERS: 1US FAERS
569Abdominal fat apronFAERS: 1US FAERS
570AbscessFAERS: 1US FAERS
571Abstains from alcoholFAERS: 1US FAERS
572Acanthosis NigricansFAERS: 1US FAERS
573AcarodermatitisFAERS: 1US FAERS
574AcidosisFAERS: 1US FAERS
575Activities of daily living impairedFAERS: 1US FAERS
576Acute Coronary SyndromeFAERS: 1US FAERS
577Acute psychosisFAERS: 1US FAERS
578Adrenal massFAERS: 1US FAERS
579AkathisiaFAERS: 1US FAERS
580Alanine aminotransferase abnormalFAERS: 1US FAERS
581Alcohol interactionFAERS: 1US FAERS
582Allergic sinusitisFAERS: 1US FAERS
583Alopecia AreataFAERS: 1US FAERS
584Amylase abnormalFAERS: 1US FAERS
585Amylase decreasedFAERS: 1US FAERS
586Anal FissureFAERS: 1US FAERS
587AneurysmFAERS: 1US FAERS
588Anti-GAD antibody positiveFAERS: 1US FAERS
589Anticoagulation drug level above therapeuticFAERS: 1US FAERS
590Antinuclear antibody increasedFAERS: 1US FAERS
591Aortic AneurysmFAERS: 1US FAERS
592Apparent deathFAERS: 1US FAERS
593ArteriosclerosisFAERS: 1US FAERS
594Arthropod biteFAERS: 1US FAERS
595Aspartate aminotransferase abnormalFAERS: 1US FAERS
596AtaxiaFAERS: 1US FAERS
597AtelectasisFAERS: 1US FAERS
598Atrial FlutterFAERS: 1US FAERS
599Atrioventricular BlockFAERS: 1US FAERS
600Auricular swellingFAERS: 1US FAERS
601AversionFAERS: 1US FAERS
602B-cell lymphoma stage IFAERS: 1US FAERS
603Bacterial testFAERS: 1US FAERS
604Bariatric gastric balloon insertionFAERS: 1US FAERS
605Benign neoplasm of adrenal glandFAERS: 1US FAERS
606Benign neoplasm of skinFAERS: 1US FAERS
607Biliary polypFAERS: 1US FAERS
608Biliary sepsisFAERS: 1US FAERS
609Bilirubin conjugated abnormalFAERS: 1US FAERS
610Bipolar DisorderFAERS: 1US FAERS
611Bladder DiverticulumFAERS: 1US FAERS
612Bladder discomfortFAERS: 1US FAERS
613Bladder spasmFAERS: 1US FAERS
614BlepharospasmFAERS: 1US FAERS
615Blood bilirubin abnormalFAERS: 1US FAERS
616Blood calcitonin abnormalFAERS: 1US FAERS
617Blood chloride increasedFAERS: 1US FAERS
618Blood cholesterol abnormalFAERS: 1US FAERS
619Blood corticotrophin increasedFAERS: 1US FAERS
620Blood cortisol increasedFAERS: 1US FAERS
621Blood electrolytes decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
622Blood immunoglobulin E increasedFAERS: 1US FAERS
623Blood insulin abnormalFAERS: 1US FAERS
624Blood ketone body increasedFAERS: 1US FAERS
625Blood lactate dehydrogenase increasedFAERS: 1US FAERS
626Blood lactic acidFAERS: 1US FAERS
627Blood magnesium abnormalFAERS: 1US FAERS
628Blood pressure inadequately controlledFAERS: 1US FAERS
629Blood sodium decreasedFAERS: 1US FAERS
630Blood sodium increasedFAERS: 1US FAERS
631Blood testosterone increasedFAERS: 1US FAERS
632Bone density decreasedFAERS: 1US FAERS
633Bone painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
634BrachydactylyFAERS: 1US FAERS
635Breast cancer stage IIFAERS: 1US FAERS
636BruxismFAERS: 1US FAERS
637Burning Mouth SyndromeFAERS: 1US FAERS
638BursitisFAERS: 1US FAERS
639Butterfly rashFAERS: 1US FAERS
640Carcinoembryonic antigen increasedFAERS: 1US FAERS
641Carcinoma in situ of skinFAERS: 1US FAERS
642Cardiac ablationFAERS: 1US FAERS
643Cardiac discomfortFAERS: 1US FAERS
644Cardiac pacemaker adjustmentFAERS: 1US FAERS
645Cardiac stress test abnormalFAERS: 1US FAERS
646Carotid intima-media thickness increasedFAERS: 1US FAERS
647Carpal Tunnel SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
648CataplexyFAERS: 1US FAERS
649CatatoniaFAERS: 1US FAERS
650Cauda Equina SyndromeFAERS: 1US FAERS
651Cell DeathFAERS: 1US FAERS
652Cerebral cystFAERS: 1US FAERS
653Cervix enlargementFAERS: 1US FAERS
654Cholelithiasis obstructiveFAERS: 1US FAERS
655Chronic gastritisFAERS: 1US FAERS
656Chronic sinusitisFAERS: 1US FAERS
657Clostridium difficile colitisFAERS: 1US FAERS
658Clostridium test positiveFAERS: 1US FAERS
659ColectomyFAERS: 1US FAERS
660Colonic Pseudo-ObstructionFAERS: 1US FAERS
661Congenital brain damageFAERS: 1US FAERS
662Congenital cystic kidney diseaseFAERS: 1US FAERS
663Continuous Positive Airway PressureFAERS: 1US FAERS
664Corneal dystrophyFAERS: 1US FAERS
665Cortisol decreasedFAERS: 1US FAERS
666Creatinine renal clearance increasedFAERS: 1US FAERS
667Croup infectiousFAERS: 1US FAERS
668CyanopsiaFAERS: 1US FAERS
669CyanosisFAERS: 1US FAERS
670CystinuriaFAERS: 1US FAERS
671Dawn phenomenonFAERS: 1US FAERS
672Decreased immune responsivenessFAERS: 1US FAERS
673DeliriumFAERS: 1US FAERS
674DementiaFAERS: 1US FAERS
675Dental cariesFAERS: 1US FAERS
676Device ineffectiveFAERS: 1US FAERS
677Diabetic AmyotrophyFAERS: 1US FAERS
678Diabetic NephropathyFAERS: 1US FAERS
679Diabetic ulcerFAERS: 1US FAERS
680Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
681Disease complicationFAERS: 1US FAERS
682Drug DependenceFAERS: 1US FAERS
683Drug dispensed to wrong patientFAERS: 1US FAERS
684Drug effect delayedFAERS: 1US FAERS
685Drug effect incompleteFAERS: 1US FAERS
686Drug label confusionFAERS: 1US FAERS
687Drug level changedFAERS: 1US FAERS
688Drug level decreasedFAERS: 1US FAERS
689Drug level increasedFAERS: 1US FAERS
690Drug monitoring procedure not performedFAERS: 1US FAERS
691Drug screen positiveFAERS: 1US FAERS
692Drug toxicityFAERS: 1US FAERS
693Drug-disease interactionFAERS: 1US FAERS
694Dry age-related macular degenerationFAERS: 1US FAERS
695Dumping SyndromeFAERS: 1US FAERS
696Duodenal UlcerFAERS: 1US FAERS
697DyscheziaFAERS: 1US FAERS
698DysenteryFAERS: 1US FAERS
699Ear congestionFAERS: 1US FAERS
700Early satietyFAERS: 1US FAERS
701Electrocardiogram QT interval abnormalFAERS: 1US FAERS
702Electrocardiogram abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
703Embolic strokeFAERS: 1US FAERS
704Emotional disorderFAERS: 1US FAERS
705Emotional povertyFAERS: 1US FAERS
706EndocarditisFAERS: 1US FAERS
707Endodontic procedureFAERS: 1US FAERS
708Endometrial adenocarcinomaFAERS: 1US FAERS
709EpididymitisFAERS: 1US FAERS
710ErysipelasFAERS: 1US FAERS
711Erythema MultiformeFAERS: 1US FAERS
712Escherichia sepsisFAERS: 1US FAERS
713Escherichia urinary tract infectionFAERS: 1US FAERS
714Essential HypertensionFAERS: 1US FAERS
715Euglycaemic diabetic ketoacidosisFAERS: 1US FAERS
716Expired device usedFAERS: 1US FAERS
717External ear painFAERS: 1US FAERS
718Extraocular Muscle ParesisFAERS: 1US FAERS
719Eyelid exfoliationFAERS: 1US FAERS
720Eyelid margin crustingFAERS: 1US FAERS
721Eyelids pruritusFAERS: 1US FAERS
722False positive investigation resultFAERS: 1US FAERS
723Feeding intoleranceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
724Flat affectFAERS: 1US FAERS
725Foaming at mouthFAERS: 1US FAERS
726Frustration tolerance decreasedFAERS: 1US FAERS
727Gallbladder hypofunctionFAERS: 1US FAERS
728Gamma-glutamyltransferase abnormalFAERS: 1US FAERS
729Gastric hypomotilityFAERS: 1US FAERS
730Gastrointestinal bacterial infectionFAERS: 1US FAERS
731Gastrointestinal hypomotilityFAERS: 1US FAERS
732Gastrointestinal motility disorderFAERS: 1US FAERS
733Gastrointestinal obstructionFAERS: 1US FAERS
734Gastrointestinal viral infectionFAERS: 1US FAERS
735GastrolithiasisFAERS: 1US FAERS
736GastroptosisFAERS: 1US FAERS
737General physical condition abnormalFAERS: 1US FAERS
738Genital burning sensationFAERS: 1US FAERS
739Genital erythemaFAERS: 1US FAERS
740Genital painFAERS: 1US FAERS
741Genital rashFAERS: 1US FAERS
742GlomerulonephritisFAERS: 1US FAERS
743GlossitisFAERS: 1US FAERS
744Glucose tolerance increasedFAERS: 1US FAERS
745GlycosuriaFAERS: 1US FAERS
746Guillain-Barre SyndromeFAERS: 1US FAERS
747Head titubationFAERS: 1US FAERS
748Hearing aid userFAERS: 1US FAERS
749Helicobacter test positiveFAERS: 1US FAERS
750HemiparesisFAERS: 1US FAERS
751Hepatic EncephalopathyFAERS: 1US FAERS
752HepatosplenomegalyFAERS: 1US FAERS
753Hormone level abnormalFAERS: 1US FAERS
754HostilityFAERS: 1US FAERS
755HydrocephalusFAERS: 1US FAERS
756HyperkeratosisFAERS: 1US FAERS
757HypermetabolismFAERS: 1US FAERS
758HyperplasiaFAERS: 128213092CTD
US FAERS
759HypokinesiaFAERS: 1US FAERS
760Idiosyncratic drug reactionFAERS: 1US FAERS
761Illness anxiety disorderFAERS: 1US FAERS
762ImmunosuppressionFAERS: 1US FAERS
763Impaired work abilityFAERS: 1US FAERS
764ImpatienceFAERS: 1US FAERS
765Implantable defibrillator insertionFAERS: 1US FAERS
766Inappropriate affectFAERS: 1US FAERS
767IncoherentFAERS: 1US FAERS
768Incorrect drug administration durationFAERS: 1US FAERS
769InfarctionFAERS: 1US FAERS
770Infusion site urticariaFAERS: 1US FAERS
771Infusion site warmthFAERS: 1US FAERS
772Inhibitory drug interactionFAERS: 1US FAERS
773Injection site calcificationFAERS: 1US FAERS
774Injection site dermatitisFAERS: 1SIDER
US FAERS
775Injection site eczemaFAERS: 1US FAERS
776Injection site hypertrophyFAERS: 1US FAERS
777Injection site joint warmthFAERS: 1US FAERS
778Injection site maculeFAERS: 1US FAERS
779Injection site necrosisFAERS: 1US FAERS
780Injection site papuleFAERS: 1US FAERS
781Injection site scabFAERS: 1US FAERS
782Intellectual DisabilityFAERS: 1US FAERS
783Intermittent ClaudicationFAERS: 1US FAERS
784Internal injuryFAERS: 1US FAERS
785Intervertebral Disc DegenerationFAERS: 1US FAERS
786Intervertebral disc disorderFAERS: 1US FAERS
787Intestinal congestionFAERS: 1US FAERS
788Intraocular pressure testFAERS: 1US FAERS
789Intraspinal abscessFAERS: 1US FAERS
790Irregular breathingFAERS: 1US FAERS
791Jejunal ulcerFAERS: 1US FAERS
792KeratorhexisFAERS: 1US FAERS
793KetonuriaFAERS: 1US FAERS
794KetosisFAERS: 1US FAERS
795Leukocytoclastic vasculitisFAERS: 1US FAERS
796LeukopeniaFAERS: 1US FAERS
797LeukoplakiaFAERS: 1US FAERS
798Limb massFAERS: 1US FAERS
799Lip pruritusFAERS: 1US FAERS
800Lipase decreasedFAERS: 1US FAERS
801LipoatrophyFAERS: 1US FAERS
802Loss of personal independence in daily activitiesFAERS: 1US FAERS
803Lyme DiseaseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
804LymphadenitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
805Macular degenerationFAERS: 1US FAERS
806Macular fibrosisFAERS: 1US FAERS
807Malignant melanoma in situFAERS: 1US FAERS
808Malignant neoplasm papilla of VaterFAERS: 1US FAERS
809Mantle cell lymphomaFAERS: 1US FAERS
810Mast cell degranulation presentFAERS: 1US FAERS
811Maternal exposure before pregnancyFAERS: 1US FAERS
812Mechanical ileusFAERS: 1US FAERS
813Meibomian gland dysfunctionFAERS: 1US FAERS
814MenopauseFAERS: 1US FAERS
815Mental impairmentFAERS: 1US FAERS
816Metastases to biliary tractFAERS: 1US FAERS
817MetastasisFAERS: 1US FAERS
818Metastatic uterine cancerFAERS: 1US FAERS
819MicroalbuminuriaFAERS: 1US FAERS
820Micturition frequency decreasedFAERS: 1US FAERS
821Middle insomniaFAERS: 1US FAERS
822Mixed Connective Tissue DiseaseFAERS: 1US FAERS
823Monoclonal immunoglobulin presentFAERS: 1US FAERS
824Motion SicknessFAERS: 1US FAERS
825Muscle FatigueFAERS: 1US FAERS
826Muscle SpasticityFAERS: 1US FAERS
827Muscular DystrophyFAERS: 1US FAERS
828Mycobacterium abscessus InfectionFAERS: 1US FAERS
829Mycobacterium fortuitum infectionFAERS: 1US FAERS
830Mycobacterium testFAERS: 1US FAERS
831Nasal discomfortFAERS: 1US FAERS
832Negative thoughtsFAERS: 1US FAERS
833Neurogenic BowelFAERS: 1US FAERS
834Neurotransmitter level alteredFAERS: 1US FAERS
835NeutropeniaFAERS: 1US FAERS
836Nipple painFAERS: 1US FAERS
837Noninfective gingivitisFAERS: 1US FAERS
838Noninfective sialoadenitisFAERS: 1US FAERS
839ObstructionFAERS: 1US FAERS
840Ocular discomfortFAERS: 1US FAERS
841Off label use of deviceFAERS: 1US FAERS
842Oral dischargeFAERS: 1US FAERS
843Oropharyngeal discomfortFAERS: 1US FAERS
844Oropharyngeal surgeryFAERS: 1US FAERS
845Orthostatic hypertensionFAERS: 1US FAERS
846OsteoporosisFAERS: 1US FAERS
847Ovarian failureFAERS: 1US FAERS
848Overgrowth fungalFAERS: 1US FAERS
849OverweightFAERS: 1US FAERS
850PancreatectomyFAERS: 1US FAERS
851Pancreatic carcinoma recurrentFAERS: 1US FAERS
852Pancreatic carcinoma stage IFAERS: 1US FAERS
853Pancreatic duct obstructionFAERS: 1US FAERS
854Pancreatic steatosisFAERS: 1US FAERS
855PapuleFAERS: 1US FAERS
856ParathyroidectomyFAERS: 1US FAERS
857ParesisFAERS: 1US FAERS
858Partner stressFAERS: 1US FAERS
859Paternal exposure timing unspecifiedFAERS: 1US FAERS
860Pelvic massFAERS: 1US FAERS
861Penile swellingFAERS: 1US FAERS
862Penis carcinomaFAERS: 1US FAERS
863Perforated ulcerFAERS: 1US FAERS
864Pericardial effusionFAERS: 1US FAERS
865PericarditisFAERS: 1US FAERS
866Perinatal strokeFAERS: 1US FAERS
867Perineal infectionFAERS: 1US FAERS
868Perineal ulcerationFAERS: 1US FAERS
869PeriodontitisFAERS: 1US FAERS
870Peripheral arterial occlusive diseaseFAERS: 1US FAERS
871Peripheral artery bypassFAERS: 1US FAERS
872Peripheral arthritisFAERS: 1US FAERS
873Peripheral venous diseaseFAERS: 1US FAERS
874Personality ChangeFAERS: 1US FAERS
875Physical disabilityFAERS: 1US FAERS
876PiloerectionFAERS: 1US FAERS
877PlagueFAERS: 1US FAERS
878PleurisyFAERS: 1US FAERS
879PolyarthritisFAERS: 1US FAERS
880Polymerase chain reaction positiveFAERS: 1US FAERS
881PolyneuropathyFAERS: 1US FAERS
882Post lumbar puncture syndromeFAERS: 1US FAERS
883Post procedural complicationFAERS: 1US FAERS
884Post procedural hypothyroidismFAERS: 1US FAERS
885Postoperative thrombosisFAERS: 1US FAERS
886Precancerous cells presentFAERS: 1US FAERS
887Precancerous skin lesionFAERS: 1US FAERS
888PresbyopiaFAERS: 1US FAERS
889Product administered at inappropriate siteFAERS: 1US FAERS
890Product contamination chemicalFAERS: 1US FAERS
891Product dispensing errorFAERS: 1US FAERS
892Product intoleranceFAERS: 1US FAERS
893Product label confusionFAERS: 1US FAERS
894Product measured potency issueFAERS: 1US FAERS
895Product used for unknown indicationFAERS: 1US FAERS
896Protein DeficiencyFAERS: 1US FAERS
897PrurigoFAERS: 1US FAERS
898Psoriasis area severity index decreasedFAERS: 1US FAERS
899Pulmonary congestionFAERS: 1US FAERS
900PyelocaliectasisFAERS: 1US FAERS
901PyuriaFAERS: 1US FAERS
902QuadriparesisFAERS: 1US FAERS
903RadiculopathyFAERS: 1US FAERS
904Rectal dischargeFAERS: 1US FAERS
905Reflux laryngitisFAERS: 1US FAERS
906Renal Artery StenosisFAERS: 1US FAERS
907Renal ColicFAERS: 1US FAERS
908Renal cancer metastaticFAERS: 1US FAERS
909Renal massFAERS: 1US FAERS
910Respiratory tract congestionFAERS: 1US FAERS
911Retinal DetachmentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
912Retinal aneurysmFAERS: 1US FAERS
913Reversible cerebral vasoconstriction syndromeFAERS: 1US FAERS
914Rheumatoid NoduleFAERS: 1US FAERS
915Rheumatoid factor increasedFAERS: 1US FAERS
916Rotator cuff syndromeFAERS: 1US FAERS
917Ruptured ectopic pregnancyFAERS: 1US FAERS
918Saliva alteredFAERS: 1US FAERS
919Salt cravingFAERS: 1US FAERS
920SchizophreniaFAERS: 1US FAERS
921ScotomaFAERS: 1US FAERS
922Self-induced vomitingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
923Septic embolusFAERS: 1US FAERS
924ShockFAERS: 1US FAERS
925Silent myocardial infarctionFAERS: 1US FAERS
926Single functional kidneyFAERS: 1US FAERS
927Sinus ArrhythmiaFAERS: 1US FAERS
928Sinus operationFAERS: 1US FAERS
929Sjogren's SyndromeFAERS: 1US FAERS
930Skeletal injuryFAERS: 1US FAERS
931Skin PapillomaFAERS: 1US FAERS
932Skin necrosisFAERS: 1US FAERS
933Skin test positiveFAERS: 1US FAERS
934Sleep TalkingFAERS: 1US FAERS
935Small intestine carcinoma metastaticFAERS: 1US FAERS
936Smear site unspecified abnormalFAERS: 1US FAERS
937Soft tissue swellingFAERS: 1US FAERS
938Sperm concentration decreasedFAERS: 1US FAERS
939Spigelian herniaFAERS: 1US FAERS
940Splenic vein thrombosisFAERS: 1US FAERS
941SpondylitisFAERS: 1US FAERS
942StapedectomyFAERS: 1US FAERS
943Staphylococcal abscessFAERS: 1US FAERS
944StarvationFAERS: 1US FAERS
945StenosisFAERS: 1US FAERS
946StillbirthFAERS: 1US FAERS
947Strangulated umbilical herniaFAERS: 1US FAERS
948Subgaleal haematomaFAERS: 1US FAERS
949Suture insertionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
950SyndactylyFAERS: 1US FAERS
951SynovitisFAERS: 1US FAERS
952Syringe issueFAERS: 1US FAERS
953Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
954Systemic lupus erythematosus rashFAERS: 1US FAERS
955Systemic mycosisFAERS: 1US FAERS
956TachyarrhythmiaFAERS: 1US FAERS
957TachyphreniaFAERS: 1US FAERS
958Temporal ArteritisFAERS: 1US FAERS
959Therapeutic procedureFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
960Therapeutic product effect variableFAERS: 1US FAERS
961Therapy non-responderFAERS: 1US FAERS
962Thermal burnFAERS: 1US FAERS
963Thrombocytopenic purpuraFAERS: 1US FAERS
964Tinea PedisFAERS: 1US FAERS
965Tongue discomfortFAERS: 1US FAERS
966Tooth InfectionFAERS: 1US FAERS
967Tooth repairFAERS: 1US FAERS
968Transaminases abnormalFAERS: 1US FAERS
969Tympanic Membrane PerforationFAERS: 1US FAERS
970Ultrasound abdomen abnormalFAERS: 1US FAERS
971Ultrasound thyroid abnormalFAERS: 1US FAERS
972Unresponsive to stimuliFAERS: 1US FAERS
973Urine albumin/creatinine ratio increasedFAERS: 1US FAERS
974Urine alcohol test positiveFAERS: 1US FAERS
975Urine flow decreasedFAERS: 1US FAERS
976Urine output increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
977Uterine CancerFAERS: 1US FAERS
978UveitisFAERS: 1US FAERS
979Venous ThrombosisFAERS: 1US FAERS
980Venous valve rupturedFAERS: 1US FAERS
981Ventricular arrhythmiaFAERS: 1US FAERS
982Violence-related symptomFAERS: 1US FAERS
983Viral load increasedFAERS: 1US FAERS
984Viral upper respiratory tract infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
985Vocal Cord ParalysisFAERS: 1US FAERS
986Vulvovaginal injuryFAERS: 1US FAERS
987Wheelchair userFAERS: 1US FAERS
988gallbladder neoplasmFAERS: 1US FAERS
989hypertensive nephropathyFAERS: 1US FAERS
990insulinomaFAERS: 1US FAERS
991liposarcomaFAERS: 1US FAERS
992muscle injuryFAERS: 1US FAERS
993Animal biteCanada Vigilance: 1Canada Vigilance
994Ankylosing spondylitisCanada Vigilance: 1Canada Vigilance
995AnorexiaSIDER
996CalcinosisCanada Vigilance: 1Canada Vigilance
997CarcinomaSIDER
998ChemotherapyCanada Vigilance: 1Canada Vigilance
999Creatinine urine abnormalCanada Vigilance: 1Canada Vigilance
1000Cyst removalCanada Vigilance: 1Canada Vigilance
1001Eye laser surgeryCanada Vigilance: 1Canada Vigilance
1002Eye muscle operationCanada Vigilance: 1Canada Vigilance
1003Food AllergyCanada Vigilance: 1Canada Vigilance
1004Gastric BypassCanada Vigilance: 1Canada Vigilance
1005Heat StrokeCanada Vigilance: 2Canada Vigilance
1006Hip surgeryCanada Vigilance: 1Canada Vigilance
1007InfestationSIDER
1008Intentional self-injuryCanada Vigilance: 2Canada Vigilance
1009Laser TherapyCanada Vigilance: 1Canada Vigilance
1010Limb crushing injuryCanada Vigilance: 1Canada Vigilance
1011LipiduriaCanada Vigilance: 1Canada Vigilance
1012Medical procedureCanada Vigilance: 1Canada Vigilance
1013PeritonitisCanada Vigilance: 1Canada Vigilance
1014PhlebitisCanada Vigilance: 1Canada Vigilance
1015PneumothoraxCanada Vigilance: 1Canada Vigilance
1016Post procedural infectionCanada Vigilance: 1Canada Vigilance
1017Post procedural swellingCanada Vigilance: 1Canada Vigilance
1018Prenatal Exposure Delayed Effects23354098CTD
1019Product leakageCanada Vigilance: 1Canada Vigilance
1020Productive CoughCanada Vigilance: 1Canada Vigilance
1021Protein urine presentCanada Vigilance: 1Canada Vigilance
1022Shunt occlusionCanada Vigilance: 1Canada Vigilance
1023Spinal fusion surgeryCanada Vigilance: 1Canada Vigilance
1024Therapeutic product effect decreasedCanada Vigilance: 5Canada Vigilance
1025TonsillectomyCanada Vigilance: 1Canada Vigilance
1026Tooth ExtractionCanada Vigilance: 2Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.